Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
03/2009
03/04/2009CN101379025A Improved method for producing nitroisourea derivative
03/03/2009US7498394 (2-Methyl)-acrylic acid 2-benzyloxycarbonyloxy-ethyl ester; higherpolymerization rates and that polymerize more completely than conventional monomers with multiple vinyl functionalities; curing efficiency, allows optimum polymer properties to be achieved with minimized irradiation times and intensities
02/2009
02/26/2009WO2009025829A1 Processes for the production of l-citrulline
02/26/2009WO2009024493A2 Polymerizable alkenyl isocyanate and polymers comprising said isocyanate
02/26/2009US20090054603 Low-cure powder coatings and methods for using the same
02/26/2009DE102007039501A1 Neues polymerisierbares Isocyanat und Polymere, enthaltend dieses Isocyanat New polymerizable isocyanate and polymers containing isocyanate this
02/25/2009EP1143965B1 Carbocyclic potassium channel inhibitors
02/25/2009CN101372465A Industrial method for extracting natural L-citrulline from water melon or smacking watermelon and other plant tissues
02/25/2009CN100463901C Alpha-ketoamide derivative, and production method and use thereof
02/19/2009WO2008139121A3 Method for the synthesis of (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl]-2-methoxy-acrylic acid
02/19/2009US20090048337 Modulation of anxiety through blockade of anandamide hydrolysis
02/19/2009US20090047435 Partially fluorinated ureas and amides
02/18/2009EP2024327A1 Benzoyl-substituted alanines
02/17/2009US7491826 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea
02/17/2009US7491739 TNF-α production inhibitors
02/17/2009US7491705 ((1S)-1-((((1S)-1-benzyl-2,3-dioxo-3-(cyclopropylamino)propyl)amino)carbonyl)-3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester; ischemic disease, immunologic disease, multiple sclerosis, Alzheimer's disease, osteoporosis, diseases caused by brain tissue damage, cataract, glaucoma
02/12/2009WO2009019199A1 Crystalline teglicar
02/12/2009US20090043099 Methods and compositions for derepression of IAP-inhibited caspase
02/11/2009CN101362727A Nitrogen-containing compound, the preparation thereof and application in amino-aldehyde resins
02/05/2009WO2009015485A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
02/05/2009CA2694724A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
02/05/2009CA2677049A1 Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
01/2009
01/29/2009WO2009013915A1 Inhibitor of plasminogen activator inhibitor-1
01/29/2009US20090030056 Novel sodium channel blockers
01/29/2009US20090030051 Inhibitors of IMPDH enzyme
01/29/2009US20090029903 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors
01/28/2009EP2018365A1 New materials for lithographic plates coatings, lithographic plates and coatings containing same, methods of preparation and use
01/28/2009EP2018364A1 Therapeutic fluoroethyl ureas
01/28/2009EP1542687B1 Small organic molecules that increase the activity of gelatinase a in ocular cells
01/28/2009CN100455566C Novel derivatives of aminocyclohexane
01/27/2009US7482487 Phenylaminoethanol derivatives as β2 receptor agonists
01/27/2009CA2637505A1 Allophanate modified diphenylmethane diisaocyanates, prepolymers thereof, and their use in the preparation of polyureas and polyureaurethanes
01/27/2009CA2238936C Process for the preparation of arylalkynyl-n-hydroxyurea derivatives having lipoxygenase inhibitory activity
01/22/2009US20090023931 Alanine racemase chiral binaphthol derivative with powerful hydrogen bond donor, and optical resolution and optical transformation methods using the same
01/22/2009US20090023813 1 1-(3-Chloro-5-trifluoromethyl-phenyl)-3-(4-chloro-3-trifluoromethyl-phenyl)-urea; sterilization, sanitation, antisepsis, disinfection, decolonisation or prevention of colonisation of the skin, gastro-intestinal tract or the nasal, ocular or dental area or any type of prosthetic device
01/22/2009US20090023731 Soluble epoxide hydrolase inhibitors
01/21/2009EP2017244A2 Chiral binaphtol derivatives as alanine racemase mimics with powerful hydrogen bond donors: their use for optical resolution and optical inversion
01/21/2009EP2016110A2 Hydrophilic stain release agents
01/20/2009CA2502856C Intermediates for retroviral protease inhibiting compounds
01/15/2009WO2009009278A1 Substituted fluoroethyl ureas as alpha 2 adrenergic agents
01/15/2009US20090018141 Kinase inhibitors, compositions thereof, and methods of use therewith
01/14/2009EP2013183A1 Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the beta2 adrenergic receptor
01/14/2009EP2013163A1 Tetrasubstituted ureas as modulators of 11-beta hydroxyl steroid dehydrogenase type 1
01/14/2009EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof
01/14/2009CN100450998C Urea derivative and process for producing the same
01/13/2009US7476399 Amide compounds such as (R)-methyl 2-(3-chloro-4-methoxybenzamido)-4-methylpentanoate and urea compounds such as 1-(2-chlorophenyl)-3-(heptan-4-yl)urea for modulating taste of food or drug products
01/08/2009US20090012061 A Method of Treating Cancer
01/08/2009DE102007030695A1 Co-crystal, useful e.g. to prepare a pharmaceutical formulation for the treatment of psychosis, neurological disorder and struma lymphomatosa, comprises an amino compound and urea as further component
01/07/2009EP1667966A4 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
01/07/2009CN101340959A Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound
01/07/2009CN101337930A Urea derivative and process for producing the same
01/01/2009US20090005452 Diphenyl Urea Derivatives
12/2008
12/31/2008WO2009001356A2 Acyl-urea derivatives and uses thereof
12/31/2008WO2008135181A3 Insecticidal substituted 2-aminoindanes
12/31/2008EP2007853A2 Process for the treatment of a product stream
12/31/2008CN101333176A Method for preparing substituent urea and co-producing hydrochloride of corresponding amines
12/30/2008US7470752 improved stability, performance
12/25/2008US20080319028 Dicycloalkylcarbamoyl Ureas As Glucokinase Activators
12/24/2008WO2008156816A2 Renin inhibitors
12/24/2008CN101331114A 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors
12/23/2008US7468440 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
12/18/2008WO2008113992A3 Gel compositions comprising urea derivatives
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/17/2008EP2003104A2 Reagent for organic synthesis and method of organic synthesis reaction with the reagent
12/17/2008EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases
12/17/2008EP1077943B1 Heterocyclic inhibitors of p38
12/17/2008CN101326157A Diphenyl urea derivatives
12/17/2008CN101326156A Diphenyl urea derivatives
12/11/2008US20080306147 Illudin Analogs Useful as Anticancer Agents
12/11/2008US20080306136 Substituted Ureas and Carbamates
12/11/2008US20080306067 Modulators of Chemokine Receptor Activity
12/10/2008CN101318914A Method for preparing urea phosphoric acid with wet-process phosphoric acid
12/03/2008EP1997802A1 Method for nitrating isourea
12/03/2008EP1996564A1 Dibenzyl amine compounds and derivatives
12/03/2008CN100439332C Novel thiourea derivatives and the pharmaceutical compositions containing thd same
12/03/2008CN100438865C Compounds having fungicidal activity and processes to make and use same
11/2008
11/27/2008WO2008143070A1 Non-covalently-bound polymer, and molecular device
11/27/2008US20080293751 Tetralin and indane derivatives and uses thereof
11/27/2008US20080293088 Two-photon probe for real-time monitoring of intracellular magnesium ions, method for preparing the two-photon probe and method for real-time monitoring of intracellular magnesium ions using the two-photon probe
11/26/2008EP1993997A2 Diphenyl urea derivatives
11/26/2008CN100436429C Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof
11/25/2008US7456133 Substituted arylketones
11/20/2008WO2008139121A2 Method for the synthesis of (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl]-2-methoxy-acrylic acid
11/20/2008US20080287499 N-deacetylthiocolchicine deriatives, their use and pharmaceutical formulations containing them
11/20/2008CA2686388A1 Method for the synthesis of (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl]-2-methoxy-acrylic acid
11/19/2008EP1687262B1 Bicyclic amide, carbamate or urea derivatives as vanilloid receptor modulators
11/19/2008CN101309898A Compounds containing aldimine
11/19/2008CN101307017A Amino-methyl substituted tetracycline compounds
11/18/2008US7452878 Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
11/13/2008WO2008135181A2 Insecticidal substituted 2-aminoindanes
11/13/2008US20080280905 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
11/12/2008EP1989174A1 Substituted cyclohexylmethyl derivatives
11/11/2008US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis
11/06/2008US20080275233 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
11/06/2008US20080275047 Tetrahydro-naphthalene derivatives
11/05/2008EP1988080A1 Insecticidal substituted 2-aminoindanes
11/05/2008EP1986498A2 Insecticidal substituted amino heterocyclic and heteroaryl derivatives
11/05/2008CN101298427A Diaryl urea compound and use thereof
11/05/2008CN100430372C Double ingredients organic gelatin and liquid crystal gelatin and its preparation method
11/04/2008US7446115 To treat pain, drug addiction, or tinnitus; selectively inhibit sodium or calcium ion channels and agonize or antagonize mu -opioid receptors; N-Benzyl-N-(2-dimethylamino-ethyl)-2-(S)-[3-(4-fluorophenyl)-ureido]-3-methyl-butyramide
1 ... 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 ... 99